Drug Eluting Stent Market (By Drug: Sirolimus, Paclitaxel, Zotaroliums, Everoliums, Bioliums, Others; By Coating Type: Polymer Based Coating, Polymer Free Coatings; By Application: Coronary Artery Diseases, Peripheral Artery Diseases; By End-User: Cardiology Centers, Ambulatory Surgery Centers (ASCs), Hospitals) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027

Table Of Content:

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Drug Eluting Stent
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Drug Eluting Stent Market By Drug
1.2.2.1. Global Drug Eluting Stent Market Revenue and Growth Rate Comparison By Drug (2016-2027)
1.2.2.2. Global Drug Eluting Stent Market Revenue Share By Drug in 2019
1.2.2.3. Sirolimus
1.2.2.4. Paclitaxel
1.2.2.5. Zotaroliums
1.2.2.6. Everoliums
1.2.2.7. Bioliums
1.2.2.8. Others
1.2.3. Drug Eluting Stent Market By Coating Type
1.2.3.1. Global Drug Eluting Stent Market Revenue and Growth Rate Comparison By Coating Type (2016-2027)
1.2.3.1.1. Polymer Based Coating
1.2.3.1.2. Polymer Free Coatings
1.2.4. Drug Eluting Stent Market By Application
1.2.4.1. Global Drug Eluting Stent Market Revenue and Growth Rate Comparison By Application (2016-2027)
1.2.4.2. Coronary Artery Diseases
1.2.4.3. Peripheral Artery Diseases
1.2.5. Drug Eluting Stent Market By End-User
1.2.5.1. Global Drug Eluting Stent Market Revenue and Growth Rate Comparison By End-User (2016-2027)
1.2.5.2. Cardiology Centers
1.2.5.3. Ambulatory Surgery Centers (ASCs)
1.2.5.4. Hospitals
1.2.6. Drug Eluting Stent Market By Geography
1.2.6.1. Global Drug Eluting Stent Market Revenue and Growth Rate Comparison by Geography (2016-2027)
1.2.6.2. North America Drug Eluting Stent Market Revenue and Growth Rate(2016-2027)
1.2.6.3. Europe Drug Eluting Stent Market Revenue and Growth Rate(2016-2027)
1.2.6.4. Asia-Pacific Drug Eluting Stent Market Revenue and Growth Rate(2016-2027)
1.2.6.5. Latin America Drug Eluting Stent Market Revenue and Growth Rate(2016-2027)
1.2.6.6. Middle East and Africa (MEA) Drug Eluting Stent Market Revenue and Growth Rate(2016-2027)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Drug Eluting Stent Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Drug Eluting Stent Major Manufacturers in 2019
3.3. R&D Status and Technology Source of Global Drug Eluting Stent Major Manufacturers in 2019
3.4. Raw Materials Sources Analysis of Global Drug Eluting Stent Major Manufacturers in 2019
CHAPTER 4. DRUG ELUTING STENT MARKET BY DRUG
4.1. Global Drug Eluting Stent Revenue By Drug
4.2. Sirolimus
4.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.3. Paclitaxel
4.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.4. Zotaroliums
4.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.5. Everoliums
4.5.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.6. Bioliums
4.6.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.7. Others
4.7.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
CHAPTER 5. DRUG ELUTING STENT MARKET BY COATING TYPE
5.1. Global Drug Eluting Stent Revenue By Coating Type
5.2. Polymer Based Coating
5.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.3. Polymer Free Coatings
5.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
CHAPTER 6. DRUG ELUTING STENT MARKET BY APPLICATION
6.1. Global Drug Eluting Stent Revenue By Application
6.2. Coronary Artery Diseases
6.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
6.3. Peripheral Artery Diseases
6.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
CHAPTER 7. DRUG ELUTING STENT MARKET BY END-USER
7.1. Global Drug Eluting Stent Revenue By End-User
7.2. Cardiology Centers
7.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
7.3. Ambulatory Surgery Centers (ASCs)
7.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
7.4. Hospitals
7.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
CHAPTER 8. NORTH AMERICA DRUG ELUTING STENT MARKET BY COUNTRY
8.1. North America Drug Eluting Stent Market Revenue and Growth Rate, 2016 - 2027 ($Million)
8.2. North America Drug Eluting Stent Market Revenue Share Comparison, 2016 & 2027 (%)
8.3. U.S.
8.3.1. U.S. Drug Eluting Stent Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
8.3.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
8.3.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
8.3.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
8.4.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
8.4.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
8.4.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
CHAPTER 9. EUROPE DRUG ELUTING STENT MARKET BY COUNTRY
9.1. Europe Drug Eluting Stent Market Revenue and Growth Rate, 2016 - 2027 ($Million)
9.2. Europe Drug Eluting Stent Market Revenue Share Comparison, 2016 & 2027 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
9.3.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
9.3.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.3.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
9.4.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
9.4.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.4.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
9.5.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
9.5.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.5.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
9.6.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
9.6.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.6.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
9.7.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
9.7.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.7.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
CHAPTER 10. ASIA-PACIFIC DRUG ELUTING STENT MARKET BY COUNTRY
10.1. Asia-Pacific Drug Eluting Stent Market Revenue and Growth Rate, 2016 - 2027 ($Million)
10.2. Asia-Pacific Drug Eluting Stent Market Revenue Share Comparison, 2016 & 2027 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
10.3.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
10.3.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
10.3.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
10.4.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
10.4.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
10.4.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
10.5.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
10.5.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
10.5.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
10.6.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
10.6.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
10.6.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
10.7.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
10.7.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
10.7.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
10.8.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
10.8.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
10.8.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
CHAPTER 11. LATIN AMERICA DRUG ELUTING STENT MARKET BY COUNTRY
11.1. Latin America Drug Eluting Stent Market Revenue and Growth Rate, 2016 - 2027 ($Million)
11.2. Latin America Drug Eluting Stent Market Revenue Share Comparison, 2016 & 2027 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
11.3.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
11.3.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
11.3.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
11.4. Mexico
11.4.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
11.4.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
11.4.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
11.4.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
11.5.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
11.5.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
11.5.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
CHAPTER 12. MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET BY COUNTRY
12.1. Middle East & Africa Drug Eluting Stent Market Revenue and Growth Rate, 2016 - 2027 ($Million)
12.2. Middle East & Africa Drug Eluting Stent Market Revenue Share Comparison, 2016 & 2027 (%)
12.3. GCC
12.3.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
12.3.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
12.3.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
12.3.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
12.4. South Africa
12.4.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
12.4.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
12.4.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
12.4.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
12.5. Rest of Middle East & Africa
12.5.1. Market Revenue and Forecast By Drug, 2016 - 2027 ($Million)
12.5.2. Market Revenue and Forecast By Coating Type, 2016 - 2027 ($Million)
12.5.3. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
12.5.4. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
CHAPTER 13. COMPANY PROFILE
13.1. Cook Medical
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Abbott Laboratories
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Cordis Corporation
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Boston Scientific Corporation
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Xtent, Inc
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Medtronic plc
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Johnson and Johnson
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Stentys
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. MicroPort Scientific Corporation
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Biotronik Inc
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Biosensors International Group
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies
13.12. Others
13.12.1. Company Snapshot
13.12.2. Overview
13.12.3. Financial Overview
13.12.4. Type Portfolio
13.12.5. Key Developments
13.12.6. Strategies
CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope